Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Government Contract opportunity from Department Of Health And Human Services was posted on May 21, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Domestic Manufacturing and Buy American Compliance

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 339112
New
Federal
SPS Sterilizer
Solicitation # 36C24526Q0758
Solicitation 36C24526Q0758 is a Firm-Fixed Price purchase order for the procurement and installation of five new steam sterilizers and five switch-over control systems for the Sterile Processing Service at the Baltimore VA Medical Center. The project includes the de-installation and disposal of existing equipment, facility work such as plumbing relocation and flooring leveling, and system validation performed by an OEM-trained representative. To ensure continuous operations, installation must be completed in two phases, with the first two units installed followed by the remaining three. While Belimed is the brand name of reference, the government will accept fully equivalent systems that meet specific dimensions and a minimum chamber volume of 275 liters. The award will be granted to the responsible quoter determined to be most advantageous based on technical capability, price, and past performance. Mandatory submission requirements include a detailed line-item worksheet, manufacturer authorization letters for distributors, and specific certifications regarding Service Contract Labor Standards. Delivery must be FOB Destination and completed within 12 months of the award. Contractors are required to maintain general liability insurance of 500,000 dollars per occurrence and comply with strict security prohibitions regarding covered telecommunications equipment. Invoices are to be submitted electronically in arrears upon the receiving and acceptance of goods and services.
245-NETWORK Contract Office 5 (36C245)

POSTED

1 day ago

DEADLINE

in 2 days

AI Contract Overview

Show more

The contract requires documentation and verification to confirm that all components are either manufactured within the United States or qualify for a waiver under the Buy American Act and the Made in America Office (MIAO) requirements. The work is associated with the NAICS code 339112, indicating involvement in surgical and medical instrument manufacturing. This subcontract is issued by the FDA Office of Acquisition and Grant Services, part of the Department of Health and Human Services, and focuses on ensuring compliance with domestic manufacturing regulations. Responses to the solicitation must be submitted by May 29, 2026. Although specific location details for performance and points of contact are not provided, the scope centers on verifying the origin of components to meet federal procurement standards. This contract emphasizes the importance of adhering to domestic sourcing rules, which is critical for meeting federal guidelines and supporting U.S. manufacturing industries in the healthcare sector.

General Info

Contract mandates verifying U.S.-made or waived components for medical instruments, deadline May 29, 2026.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

339112 - Surgical and Medical Instrument ManufacturingView NAICS

Place of Performance

MD, USA

Set-Aside

NONE

Documents

This scope was carved out of 75F40126SSN133891.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Upper Limb Bypass Prothesis System to include TASKA CX

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Provide documentation and verification that all components are manufactured in the U.S. or qualify for a waiver under the Buy American Act and MIAO requirements.

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration's Center for Drug Evaluation and Research is seeking a firm-fixed-price purchase order for human induced pluripotent stem cell-derived hindbrain organoid functional assay services. The contract involves the provision of human hindbrain organoids and associated culture materials, with twelve scheduled deliveries to the FDA White Oak Campus in Silver Spring, Maryland. The first delivery will consist of 96 organoids, followed by eleven subsequent deliveries of 48 organoids each. The contractor will perform functional characterization at its own laboratory using three-dimensional multi-electrode array technology to evaluate electrophysiological responses to FDA-identified drug and reversal-agent combinations. Key deliverables include the raw and analyzed data, analysis files, and comprehensive study reports. The anticipated period of performance is 18 months from the date of award. This is a commercial service acquisition under FAR Part 12, intended as a sole-source award to OrganoTherapeutics SARL based on market research identifying them as the only source capable of meeting the full requirement. Award will be based on best value, with technical capability and past performance weighted more heavily than price. All invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

1 day ago

DEADLINE

in 5 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS